Results 81 to 90 of about 486,331 (169)

Central nervous system penetration of imatinib in acute lymphoblastic leukemia: Pharmacokinetic analysis and clinical implications. [PDF]

Cancer Chemother Pharmacol
Rasmussen ASB, Rank CU, Christensen IJ, Weimann A, Hansen K, Thastrup M, Yang T, Lund TM, Wik HS, Vogt H, Norén-Nyström U, Vaitkeviciene G, Albertsen BK, Wehner PS, Als-Nielsen B, Andersen CL, Dalhoff K, Schmiegelow K.   +17 more
europepmc   +1 more source

Cognitive near-singularity: a possibility theorem and a witness-based protocol with a corpus case study. [PDF]

Front Artif Intell
Williams AE.
europepmc   +1 more source

Patterns of central nervous system disease and molecular landscape in epidermal growth factor receptor exon 20 insertion mutated non-small cell carcinoma. [PDF]

Transl Lung Cancer Res
Reyes A, Mambetsariev I, Fricke J, Young JR, Chen BT, Amini A, Ladbury C, Arias-Romero J, Nguyen D, Pisick E, Doctor V, Tan B, Afkhami M, Kareem W, Li X, Salgia R.   +15 more
europepmc   +1 more source

Brain and central nervous system cancer burden in children across Asia. [PDF]

iScience
Zhang W, Lv W, Chen R, Liu T.
europepmc   +1 more source

From Lysosomal Storage to Neurodegeneration: Sphingolipid Signaling as a Driver of CNS Pathology and Biomarker Strategy in Neuronopathic Gaucher Disease. [PDF]

Int J Mol Sci
Casazza K, Kartha RV, Jarnes JR.
europepmc   +1 more source

Supramolecular Assembly of Plant Cell Wall-Derived Cellulose Nanosheets with Polyacrylamide for Sustainable Sand Stabilization. [PDF]

Polymers (Basel)
Xie F, Zha X, Guo X, Fu Z, Lu Y.
europepmc   +1 more source

Double-dose furmonertinib for patients with osimertinib-resistant advanced NSCLC: therapeutic efficacy and safety. [PDF]

Front Oncol
Wei Y, Xu Y, Ren Q, Zhang Y, Zhang C, Wang L.   +5 more
europepmc   +1 more source

Ruxolitinib Penetrates Blood Brain Barrier and Reduces the Cytokine Storm in Patients With Haemophagocytic Lymphohistiocytosis. [PDF]

J Cell Mol Med
Ji W, Qing K, Ren J, Xue K, Fang J, Wu S.   +5 more
europepmc   +1 more source

Duration of systemic therapy in patients with metastatic <i>EGFR</i>-mutated non-small cell lung cancer and brain metastases. [PDF]

Transl Lung Cancer Res
Yan M, Tjong M, Coburn N, Nguyen L, Sahgal A, Louie AV, Parmar A.   +6 more
europepmc   +1 more source

The Efficacy and Toxicity of CNS Prophylaxis in Diffuse Large B-Cell Lymphoma (CLSG-CNS-01): A Randomized, Multicenter, Prospective Phase 3 Trial. [PDF]

Hematol Oncol
Mocikova H, Gaherova L, Jancarkova T, Suri A, Janikova A, Steinerova K, Belada D, Pytlik R, Duras J, Trnkova M, Blahovcova P, Kozak T, Trneny M.   +12 more
europepmc   +1 more source